Search

Design Therapeutics Inc

Gesloten

12.63 0.4

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.53

Max

12.77

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.6M

-18M

EPS

-0.29

Werknemers

54

EBITDA

534K

-17M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+65.08% upside

Dividenden

By Acuity

Volgende Winsten

5 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

65M

865M

Vorige openingsprijs

12.23

Vorige sluitingsprijs

12.63

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 jul 2026, 23:51 UTC

Cryptocurrency Gains Amid Investor Shift from Gold, While Geopolitical Tensions and Economic Data Loom Over Financial Markets.

18 jul 2026, 23:51 UTC

Bitcoin and Ethereum rise amid investor shift from gold, while geopolitical tensions and U.S. Treasury shifts signal potential market volatility ahead of key economic data releases.

18 jul 2026, 23:51 UTC

Bitcoin and Ethereum rise as investors shift from gold amid market volatility, while U.S. labor participation hits a 50-year low and geopolitical tensions escalate in the Middle East.

18 jul 2026, 23:51 UTC

Bitcoin and Ethereum gain momentum amid investor shift from gold, while geopolitical tensions and upcoming economic data influence market sentiment.

18 jul 2026, 23:41 UTC

Canada's Retail Sales Ex Autos MoM report on July 23, 2026, forecasts modest growth at 0.4%, amid cautious market sentiment due to geopolitical tensions and economic uncertainties.

18 jul 2026, 23:41 UTC

Chicago Fed National Activity Index Release on July 23, 2026, Expected to Reflect Economic Fluctuations Amid Geopolitical Tensions and Rising Oil Prices.

18 jul 2026, 23:31 UTC

ECB Set to Raise Interest Rates Amid Rising Inflation Concerns Driven by Geopolitical Tensions on July 23, 2026.

18 jul 2026, 23:31 UTC

Euro Area's Deposit Facility Rate Expected to Hold Steady at 2.25% Amid Geopolitical Tensions and Inflation Concerns

18 jul 2026, 23:21 UTC

China's Loan Prime Rate (LPR) 1Y set for July 20, 2026 at a forecasted 0.03%, amid cautious investor sentiment and rising inflation concerns.

18 jul 2026, 23:21 UTC

China's Loan Prime Rate Expected to Remain Steady at 3.50% for Five Years Amid Stable Market Sentiment

18 jul 2026, 22:51 UTC

Japan's Inflation Rate YoY Release on July 23, 2026 Sparks Concerns Over Economic Pressures and Market Volatility Amid Rising Interest Rates.

18 jul 2026, 22:51 UTC

Japan's Core Inflation Rate YoY Expected to Rise to 1.6% Amidst CFO Concerns Over Economic Pressures and Geopolitical Tensions

18 jul 2026, 22:41 UTC

Mortgage Rates Hit Nine-Month High Amid Inflation Concerns and Cautious Market Sentiment Ahead of Upcoming Data Release.

18 jul 2026, 22:41 UTC

Canada's Inflation Rate Expected to Drop Significantly Amid Geopolitical Tensions and Recent Price Declines

18 jul 2026, 22:41 UTC

Canada's Inflation Rate Expected to Decline Slightly in June Amid Geopolitical Tensions and Volatile Market Conditions

18 jul 2026, 22:41 UTC

Canada's Core Inflation Rate Release on July 20, 2026: Market Anticipates Lower Figures Amid Geopolitical Tensions and Recent CPI Drop.

18 jul 2026, 22:31 UTC

Japan's June 2026 export growth forecasted at 0.186%, amid market volatility and geopolitical tensions impacting major exporters.

18 jul 2026, 22:31 UTC

Japan's Balance of Trade report predicts a -120 billion yen deficit amid rising import costs and negative market sentiment, as stock indices decline due to global economic concerns.

18 jul 2026, 22:31 UTC

Brazil's Central Bank to announce SELIC interest rate decision on July 20, 2026, amid stable market sentiment.

18 jul 2026, 22:31 UTC

UK Consumer Confidence Expected to Decline to -21.0 Amid Rising Inflation and Geopolitical Tensions

18 jul 2026, 22:21 UTC

Australia's S&P Global Services PMI Flash Release on July 23, 2026: Key Indicator Amid Mixed Market Sentiment and Inflation Concerns.

18 jul 2026, 22:21 UTC

Optimism Grows Ahead of Australia's S&P Global Manufacturing PMI Flash Release Amid Strong Industrial Performance and Positive Investor Sentiment

18 jul 2026, 22:11 UTC

Turkey's TCMB Expected to Maintain 37% Interest Rate Amid Inflation Pressures and Geopolitical Tensions on July 23, 2026.

18 jul 2026, 22:01 UTC

South Korea's Q2 GDP Growth Rate Estimate Set for July 22 Amid Cautious Optimism and External Concerns.

18 jul 2026, 22:01 UTC

South Korea's Upcoming GDP Growth Rate Release on July 22, 2026, Sparks Investor Anxiety Amid Geopolitical Tensions and Foreign Sell-Offs.

18 jul 2026, 21:11 UTC

UK Factory Orders Forecasted at -40.0 Amid Mixed Sentiment and Economic Pressures Ahead of July 2026 Release

18 jul 2026, 21:11 UTC

UK CBI Business Optimism Index for Q3 2026 set to reveal cautious optimism amid geopolitical tensions and inflationary pressures.

18 jul 2026, 20:51 UTC

Correlated Moves
Macro News

Bitcoin is trading higher today amid rising geopolitical tensions and crude oil prices. Ethereum's movement reflects similar market dynamics in the cryptocurrency sector.

18 jul 2026, 20:01 UTC

Macro News

Crude oil prices rose in after-market hours amid escalating geopolitical tensions affecting shipping routes, particularly following military actions involving Iran and U.S. forces.

18 jul 2026, 20:01 UTC

API Crude Oil Stock Change Report Set for July 21, Amid Geopolitical Tensions Driving Price Volatility and Supply Concerns.

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

65.08% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 20.75 USD  65.08%

Hoogste 22 USD

Laagste 20 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat